CDSCO still faces challenges like chronic understaffing, gaps in technical skills, weak lab infra and fragmented approvals. About a decade ...

Oyo's parent company, PRISM, has filed for a ₹6,650 crore IPO, marking its third attempt to go public after previous delays and withdrawals...

Andhra Pradesh has secured investments totaling Rs 11.77 lakh crore over two years, projected to create over 10 lakh jobs. Minister TG Bhar...

A NITI Aayog report highlights that India's visa system needs significant upgrades to match global tourism leaders, hindering repeat and hi...

The government has provided substantial credit guarantees, totaling Rs 13 lakh crore, to micro and small enterprises, significantly boostin...

Over 30 years ago in 1995, Amish Anantrai Modi had booked some shops in a project for a total consideration of Rs 25 lakh. In his complaint...

Mumbai's food safety standards took a hit as the FDA suspended licenses for six eateries, including the Nariman Point restaurant Flint & Wa...

EPFO 3.0 aims to modernize provident fund services through upgraded technology, faster claim processing, simplified withdrawals, digital re...

States are rapidly digitizing land records to streamline India's complex property market. This move aims to curb disputes, speed up transac...

The SC said that the homebuyer can make a claim for compensation for delayed possession. “The subsequent receipt of possession cannot, by i...

The Cabinet Secretariat is pushing for faster government processes and reduced red tape to expedite key central projects. New directives ai...

Homebuyers have won a significant victory as MahaREAT ruled a builder cannot use inter-authority disputes to justify possession delays exce...

Indian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...

Indian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...

Shopify is poised to ban all vape sales from its platform this week, responding to pressure from U.S. state attorneys general. This move ta...

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...

Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...